Two Sigma Investments, LP Haemonetics Corp Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 77,474 shares of HAE stock, worth $5.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

77,474

Previous 109,704 29.38%

Holding current value

$5.84 Million

Previous $9.08 Million 31.39%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.45 - $91.58 $2.34 Million - $2.95 Million	-32,230 Reduced 29.38%	77,474 $6.23 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $8.91 Million - $10.7 Million	109,704 New	109,704 $9.08 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $3.13 Million - $3.54 Million	-37,896 Reduced 69.43%	16,687 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $2.14 Million - $2.36 Million	26,418 Added 93.8%	54,583 $4.65 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $5.96 Million - $7.42 Million	-81,935 Reduced 74.42%	28,165 $2.33 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $2.57 Million - $3 Million	34,771 Added 46.16%	110,100 $8.66 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $11.8 Million - $14.6 Million	-186,125 Reduced 71.19%	75,329 $5.58 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $9.32 Million - $12.5 Million	-189,225 Reduced 41.99%	261,454 $17 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $1.13 Million - $1.63 Million	25,784 Added 6.07%	450,679 $28.5 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $3.19 Million - $4.8 Million	-64,389 Reduced 13.16%	424,895 $22.5 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $12.9 Million - $15.8 Million	223,568 Added 84.14%	489,284 $34.5 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $7.38 Million - $16.9 Million	142,425 Added 115.52%	265,716 $17.7 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $10.5 Million - $13.2 Million	94,461 Added 327.65%	123,291 $13.7 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $21.3 Million - $28.8 Million	-239,816 Reduced 89.27%	28,830 $3.42 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $3.66 Million - $4.53 Million	48,394 Added 21.97%	268,646 $23.4 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $14.6 Million - $20.4 Million	171,452 Added 351.34%	220,252 $19.7 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $13.6 Million - $22.2 Million	-182,362 Reduced 78.89%	48,800 $4.86 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $19.1 Million - $21.6 Million	166,903 Added 259.73%	231,162 $26.6 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $5.49 Million - $6.49 Million	46,866 Added 269.45%	64,259 $8.11 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $6.78 Million - $9.98 Million	-82,907 Reduced 82.66%	17,393 $2.09 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $4.54 Million - $5.56 Million	54,475 Added 118.88%	100,300 $8.77 Million
Q4 2018 Feb 14, 2019	BUY	$90.66 - $116.63 $4.15 Million - $5.34 Million	45,825 New	45,825 $4.59 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $9.06 Million - $11.5 Million	-100,701 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $6.59 Million - $8.82 Million	92,159 Added 1078.89%	100,701 $9.03 Million
Q1 2018 May 15, 2018	SELL	$60.72 - $74.41 $14.3 Million - $17.5 Million	-235,481 Reduced 96.5%	8,542 $625,000
Q4 2017 Feb 14, 2018	BUY	$44.96 - $58.99 $10.4 Million - $13.7 Million	231,579 Added 1860.97%	244,023 $14.2 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $502,488 - $558,362	12,444	12,444 $558,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Haemonetics Corp Transaction History